1. |
Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 2010, 51(6): 1069-1077.
|
2. |
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl), 2022, 135(5): 584-590.
|
3. |
Neelapu SS, Tummala S, Kebriaei P, et al. Chimeric antigen receptor T-cell therapy-assessment and management of toxicities. Nat Rev Clin Oncol, 2018, 15(1): 47-62.
|
4. |
McCune JS, Wang T, Bo-Subait K, et al. Association of antiepileptic medications with outcomes after allogeneic hematopoietic cell transplantation with busulfan/cyslophosphamide conditioning. Biol Blood Marrow Transplant, 2019, 25(7): 1424-1431.
|
5. |
Adès L, Duployez N, Guerci-Bresler A, et al. A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations. Br J Haematol, 2022, 198(3): 535-544.
|
6. |
Fukuyama T, Tanaka M, Nakazawa Y, et al. Prophylactic treatment for hypertension and seizure in a case of allo-geneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome. Pediatr Transplant, 2011, 15(8): E169-E173.
|
7. |
唐静, 刘清扬, 林京玉, 等. 丙戊酸相关血液系统不良反应严重程度的相关因素分析. 实用药物与临床2020, 23(5): 466-470.
|
8. |
Danese E, Montagnana M, Favaloro EJ, et al. Drug-induced thrombocytopenia: mechanisms and laboratory diagnostics. Semin Thromb Hemost, 2020, 46(3): 264-274.
|
9. |
梁栋, 罗莉, 程均祥. 左乙拉西坦不良反应分析. 中国药物警讯, 2023, 20(9): 1054-1059.
|
10. |
中华医学会血液学分会. 骨髓增生异常综合征中国诊断与治疗指南(2019年版). 中华血液学杂志, 2019, 40(2): 89-97.
|
11. |
Lin CY, Chang CW, Tseng WJ, et al. Therapeutic drug monitoring of perampanel: clinical utility and impact of co-medication on pharmacokinetic variability. Heliyon, 2024, 10(1): e23962.
|
12. |
Yang C, Liu Z, Peng Y, et al. Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study. Front Pharmacol, 2023, 14: 1186786.
|
13. |
Majid O, Laurenza A, Ferry J, et al. Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials. Br J Clin Pharmacol. 2016, 82(2): 422–430.
|
14. |
De Liso P, Vigevano F, Specchio N, et al. Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies-an Italian observational multicenter study. Epilepsy Res, 2016, 127: 93-100.
|
15. |
陈国锋, 李国铭, 柯钟灵, 等. 吡仑帕奈在2~12岁儿童药物难治性癫痫添加治疗中的疗效观察. 中华实用儿科临床杂志, 2022, 37(3): 182-185.
|
16. |
Zhao T, Li HJ, Feng JR, et al. Efficacy, tolerability, and safety of treatment with Perampanel in Pediatric patients with epilepsy aged ≥4 years: a real-life observational study. Journal of Child Neurology, 2023, 38: 414-421.
|
17. |
姜玉武, 王艺, 钟建民, 等. 拉考沙胺添加治疗在中国儿童局灶性癫痫发作中的安全性与有效性─一项全球多中心单臂研究期中分析. 中华实用儿科临床杂志, 2023, 38(11): 850-856.
|
18. |
Farkas V, Steinborn B, Flamini JR, et al. Efficacy and tolarebility of adjunctive Lacosamide in pediatric patients with focal seizures. Neurology, 2019, 93(12): e1212-e1226.
|
19. |
Mohammadi T, Nasiri J, Ghazavi MR, et al. Efficacy of Lacosamide add-on therapy on refractory focal epilepsies in children and adolesecnts: an open-label clinical trial. J Res Pharm Pract, 2022, 11(3): 109-115.
|
20. |
Ferreira JA, Le Pichon JB, Abdelmoity AT, et al. Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – an open-label trial. Seizure. 2019, 71: 166–173.
|
21. |
Farkas MK, Beller C, Bozorg A, et al. Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: an open-label, phase 2/3 trial. Epilepsia Open, 2023, 8(1): 146-153.
|
22. |
Lattanzi S, Trinka E, Zaccara G, et al. Third-generation antiseizure medications for adjunctive treatment of focal-onset seizures in adults: a systematic review and network meta-analysis. Drugs, 2022, 82(2): 199-218.
|
23. |
肖潇, 汤继宏, 张兵兵, 等. 拉考沙胺及吡仑帕奈添加治疗FIRES2例报告及文献复习. 甘肃医药, 2023, 42(1): 91-93+96.
|